Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China.
Overview & Synopsis
Open access biomedical research article published in Hum Vaccin Immunother.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China. |
|---|---|
| Author / Organization | Shi X, Han S, Wu C, Wang X, Huang J, Chen W, Liu X, Wei S, Liu J, Guo X, Wang C, Wang S, Zhang M, Guo X, Zhao W, Chen H, Li Q |
| Subject & Discipline | Hum Vaccin Immunother |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-64425 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |